Nine-month interim report (Q3) 2024 (unaudited)

Company release No. 19/2024 ALK delivers 18% organic revenue growth and an operating profit margin of 23% in Q3Revenue growth was mainly driven by a continued strong momentum in tablet sales and a recovery in Jext ®sales. Europe and International markets were key contributors to growth. The operating profit improved in line with ALK's financial ambitions, and the full-year outlook remains unchanged. Q3 performance highlights Comparative figures for Q3 2023 are shown in brackets...

Hørsholm, 14/11/2024 (informazione.it - comunicati stampa - economia)

ALK delivers 18% organic revenue growth and an operating profit margin of 23% in Q3

Revenue growth was mainly driven by a continued strong momentum in tablet sales and a recovery in Jext sales. Europe and International markets were key contributors to growth. The operating profit improved in line with ALK's financial ambitions, and the full-year outlook remains unchanged.

Q3 performance highlights

Comparative figures for Q3 2023 are shown in brackets. Revenue growth rates are stated in local currencies, unless otherwise indicated.

Financial highlights

l.c.: local currency; r.c.: reported currency

Progress on strategic priorities

2024 full-year outlook remains unchanged

Commenting on the results, CEO Peter Halling said: “The results in Q3 confirm that we are on track to improve revenue and earnings for the sixth consecutive year, and we are particularly encouraged by the robust tablet growth and the positive impact of our optimisation initiatives. The implementation of our Allergy+ strategy is progressing well, as evidenced by the newly announced license agreement with ARS Pharma, granting ALK rights to the adrenaline nasal spray neffy . We are thereby taking steps to build new revenue streams to supplement our core offering in respiratory allergy.”

Hørsholm, 14 November 2024

ALK-Abelló A/S
For further information, contact:
Investor Relations : Per Plotnikof, tel. +45 4574 7527, mobile +45 2261 2525
Media: Maiken Riise Andersen, tel. +45 5054 1434

ALK is hosting a conference call for analysts and investors at 1.30 p.m. (CET) on 14 November 2024 at which the executive leadership team will review the financial results and the outlook. The conference call will be audio cast on https://ir.alk.net where the relevant presentation will be available shortly before the call begins.

To register for the conference call, please use this link and follow the registration instructions. You will receive an email from diamondpass@choruscall.com with dial-in details, including a passcode and a pin code. Please make sure to whitelist diamondpass@choruscall.com and/or check your spam filter. We advise you to register well in advance and to call in before 1.25 p.m. (CET).

Attachment